Paul Ndaya Oloo

Coalition for Epidemic Preparedness Innovations

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial”.

Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial

Nature Medicine(2021)10.1038/s41591-021-01470-y

N/A

2.9DataRank · unranked

103 citations

Laura C. Steinhardt, Reuben Yego, Ryan E. Wiegand, Phillip A. Swanson, Natasha KC +25 more

Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00273-0

N/A

2.6DataRank · unranked

72 citations

Daniel Ansong, Simon Kariuki, Samuel Adjei, Anne Bollaerts, Christian F. Ockenhouse +35 more